Case Report: Clinical Experience With Avelumab in Patients With Metastatic Merkel Cell Carcinoma and Brain Metastases Treated in Europe

by Kate Fife, Pauline Tétu, Jessica Prabhakaran, Celeste Lebbé, Giovanni Grignani
Published 2021-05-01

Optimal cut-off for neutrophil-to-lymphocyte ratio: Fact or Fantasy? A prospective cohort study in metastatic cancer patients.

by Yann-Alexandre Vano, Stéphane Oudard, Marie-Agnès By, Pauline Têtu, Constance Thibault, Hail Aboudagga, Florian Scotté, Reza Elaidi
Published 2018-01-01

Reintroduction of immune-checkpoint inhibitors after immune-related meningitis: a case series of melanoma patients

by Stefania Cuzzubbo, Pauline Tetu, Sarah Guegan, Renata Ursu, Catherine Belin, Lila Sirven Villaros, Julie Mazoyer, Coralie Lheure, Antoine F Carpentier
Published 2020-07-01

FGF2 Induces Resistance to Nilotinib through MAPK Pathway Activation in KIT Mutated Melanoma

by Pauline Tétu, Julie Delyon, Jocelyne André, Coralie Reger de Moura, Malak Sabbah, Ghanem E Ghanem, Maxime Battistella, Samia Mourah, Céleste Lebbé, Nicolas Dumaz
Published 2020-04-01

Impact of New Systemic Treatment and Radiotherapy in Melanoma Patients with Leptomeningeal Metastases

by Pauline Tétu, Lila Sirven-Villaros, Stefania Cuzzubbo, Renata Ursu, Barouyr Baroudjian, Julie Delyon, François Nataf, Constance De Margerie-Mellon, Clara Allayous, Wendy Lefevre, Antoine F. Carpentier, Céleste Lebbé
Published 2020-09-01

Increased risk of brain metastases among patients with melanoma and PROM2 expression in metastatic lymph nodes

by Thuy Thi Nguyen, Guillaume Gapihan, Pauline Tetu, Frédéric Pamoukdjian, Morad El Bouchtaoui, Christophe Lebœuf, Jean‐Paul Feugeas, Justine Paris, Barouyr Baroudjian, Julie Delyon, Samia Mourah, Céleste Lebbé, Anne Janin, Guilhem Bousquet, Maxime Battistella
Published 2020-12-01